ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 275 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $44,130 | -96.3% | 1,543 | -96.0% | 0.00% | -100.0% |
| Q4 2023 | $1,182,262 | -5.2% | 38,636 | -16.8% | 0.01% | -14.3% |
| Q3 2023 | $1,247,279 | -79.1% | 46,419 | -72.2% | 0.01% | -76.7% |
| Q2 2023 | $5,957,181 | +128.2% | 167,055 | +299.6% | 0.03% | +400.0% |
| Q3 2021 | $2,610,000 | +18.7% | 41,803 | +57.4% | 0.01% | +20.0% |
| Q2 2021 | $2,199,000 | +6.0% | 26,554 | -15.1% | 0.01% | 0.0% |
| Q1 2021 | $2,074,000 | -23.5% | 31,273 | -11.5% | 0.01% | -28.6% |
| Q4 2020 | $2,710,000 | +489.1% | 35,321 | +120.8% | 0.01% | +600.0% |
| Q1 2020 | $460,000 | -48.2% | 16,000 | +14.3% | 0.00% | -66.7% |
| Q4 2019 | $888,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |